Quantitative structure-activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2009-03-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2008.11.059PMID 19250829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Data Analysis and Graphics Using R: An Example-Based Approach

  2010cited by this paper
• Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.

  2007cited by this paper
• Cannabinoids and psychosis.

  2007cited by this paper
• The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.

  2007cited by this paper
• Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis

  2007cited by this paper
• Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies

  2006cited by this paper
• CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

  2006cited by this paper
• A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.

  2006cited by this paper
• A molecular link between the active component of marijuana and Alzheimer's disease pathology.

  2006cited by this paper
• Cannabinoid pharmacology: the first 66 years

  2006cited by this paper
• Quantum mechanics in structure-based drug design.

  2006cited by this paper
• Cannabinoid derivatives induce cell death in pancreatic MIA PaCa‐2 cells via a receptor‐independent mechanism

  2006cited by this paper
• Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

  2006cited by this paper
• Cannabinoids in medicine: A review of their therapeutic potential.

  2006cited by this paper
• AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.

  2006cited by this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cited by this paper
• A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.

  2006cited by this paper
• Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.

  2006cited by this paper
• 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.

  2006cited by this paper
• Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma

  2006cited by this paper
• Cannabinoids induces apoptosis in human colon cancer cells via CB2 receptor activation

  2006cited by this paper
• 3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.

  2006cited by this paper
• The endocannabinoid system: current pharmacological research and therapeutic possibilities.

  2006cited by this paper
• The cytotoxicity of ortho alkyl substituted 4-X-phenols: a QSAR based on theoretical bond lengths and electron densities.

  2006cited by this paper
• Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

  2006cited by this paper
• QMQSAR: Utilization of a semiempirical probe potential in a field‐based QSAR method

  2005cited by this paper
• Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.

  2005cited by this paper
• A cannabinoid pharmacotherapy for chemotherapy-evoked painful peripheral neuropathy.

  2005cited by this paper
• Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.

  2005cited by this paper
• Natural cannabinoids: templates for drug discovery.

  2005cited by this paper
• Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.

  2005cited by this paper
• Adamantyl cannabinoids: a novel class of cannabinergic ligands.

  2005cited by this paper
• The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

  2005cited by this paper
• Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway.

  2005cited by this paper
• Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands.

  2005cited by this paper
• A study on the influence of molecular properties in the psychoactivity of cannabinoid compounds

  2005cited by this paper
• Cannabinoid receptor as a novel target for the treatment of prostate cancer.

  2005cited by this paper
• Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

  2005cited by this paper
• The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

  2005cited by this paper
• Description of the Electronic Structure of Organic Chemicals Using Semiempirical and Ab Initio Methods for Development of Toxicological QSARs

  2005cited by this paper
• Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors.

  2004cited by this paper
• Theoretical analysis of the NMR and electronic structure of novel Δ8-THC derivatives

  2004cited by this paper
• Recent advances in CB1 cannabinoid receptor antagonists.

  2004cited by this paper
• Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells

  2004cited by this paper
• Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines

  2004cited by this paper
• Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor‐1

  2004cited by this paper
• Hypothesis: cannabinoid therapy for the treatment of gliomas?

  2004cited by this paper
• Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1.

  2004cited by this paper
• Novel Pharmacological Targets for Cannabinoids

  2004cited by this paper
• Cannabinoids and glaucoma

  2004cited by this paper
• Thin plate regression splines

  2003cited by this paper
• 3D structural model of the G‐protein‐coupled cannabinoid CB2 receptor

  2003cited by this paper
• Synthesis and testing of novel phenyl substituted side-chain analogues of classical cannabinoids.

  2003cited by this paper
• Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.

  2002cited by this paper
• The role of quantitative structure-activity relationships (QSAR) in biomolecular discovery

  2002cited by this paper
• Cannabinoid receptors and their ligands.

  2002cited by this paper
• Cannabinergic ligands.

  2002cited by this paper
• Targeting the endocannabinoid system in cancer therapy: A call for further research

  2002cited by this paper
• A 3D QSAR Pharmacophore Model and Quantum Chemical Structure-Activity Analysis of Chloroquine(CQ)-Resistance Reversal

  2002cited by this paper
• Theoretical hydrogen bonding parameters for drug design.

  2001cited by this paper
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

  2001cited by this paper
• The synthetic cannabinoid WIN55212‐2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies

  2001cited by this paper
• A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.

  2000cited by this paper
• QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency.

  2000cited by this paper
• Using theoretical descriptors in linear free energy relationships: characterizing several polarity, acid and basicity scales

  1999cited by this paper
• Pharmacology of cannabinoid receptor ligands.

  1999cited by this paper
• Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.

  1998cited by this paper
• Cannabinoid receptors and their endogenous agonists.

  1998cited by this paper
• A universal model for the quantum mechanical calculation of free energies of solvation in non-aqueous solvents

  1997cited by this paper
• Quantum-Chemical Descriptors in QSAR/QSPR Studies.

  1996cited by this paper
• Pharmacophoric requirements for cannabinoid side chains. Naphthoyl and naphthylmethyl substituted Δ8-tetrahydrocannabinol analogs†

  1996cited by this paper
• Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics.

  1995cited by this paper
• Diagnostics statistics in QSAR

  1995cited by this paper
• Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.

  1991cited by this paper
• Natural population analysis

  1985cited by this paper
• Molecular orbital study of the ring nitrogen basicity of various dihydrofolate reductase inhibitors

  1985cited by this paper
• Applied Linear Regression Models

  1983cited by this paper
• The Relationship Between Variable Selection and Data Agumentation and a Method for Prediction

  1974cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• Identification functional characterization of brainstem cannabinoid CB2 receptors.

  year unknowncited by this paper

• New Metal Complexes Based on Chromone and Triazine Moieties as Potential Antitumor Agents: Full Structural Elucidation, Theoretical Calculations, and Biological Studies

  2025cites this paper
• Determination of in vitro antifungal activity of dihydroisoxazole dimethanol compound against dermatophytes obtained from clinical isolates and design of some new dihydroisoxazole dimethanol compounds

  2024cites this paper
• Selective Metal‐Coordinated Nanodrugs Based on Thiazine Moiety for Anticancer Therapeutics: Spectroscopic, Theoretical, and Molecular Docking Studies

  2024cites this paper
• COMPARISON OF BIOPHARMACEUTICAL PARAMETERS OF CANNABINOIDS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY QSAR METHOD

  2023cites this paper
• Study of Antiviral Activity of Some Pyrimidine Ring Containing Compounds against COVID-19 Based on Molecular Docking and Quantum Chemical Calculations by DFT Method

  2022cites this paper
• Identification of structural factors that affect binding to cannabinoid receptor type 1

  2022cites this paper
• Novel metal complexes with pyrano[3,2‐ c ]quinoline‐3‐carboxaldehyde: Synthesis, spectroscopic, molecular modeling, QSAR, antimicrobial, and antitumor studies

  2021cites this paper
• Determination of the structural, electronic, optoelectronic and thermodynamic properties of the methylxanthine molecules theophylline and theobromine

  2020cites this paper
• User-Friendly Quantum Mechanics: Applications for Drug Discovery.

  2020cites this paper
• Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin

  2020cites this paper
• Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.

  2012cites this paper
• Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.

  2011cites this paper
• The many faces of the adamantyl group in drug design.

  2011cites this paper
• The great descriptor melting pot: mixing descriptors for the common good of QSAR models

  2011cites this paper
• Medicinal Chemistry Research Synthesis, Characterization, Antimicrobial Activity, and Qsar Studies on Substituted Oxadiazaboroles

  year unknowncites this paper